Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2015 1
2018 1
2019 1
2020 1
2021 4
2022 1
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Abrogation of stemness in osteosarcoma by the mithramycin analog EC-8042 is mediated by its ability to inhibit NOTCH-1 signaling.
Estupiñán Ó, Rey V, Tornín J, Murillo D, Gallego B, Huergo C, Blanco-Lorenzo V, Victoria González M, Rodríguez A, Moris F, González J, Ayllón V, Ramos-Mejía V, Bigas A, Rodríguez R. Estupiñán Ó, et al. Among authors: blanco lorenzo v. Biomed Pharmacother. 2023 Jun;162:114627. doi: 10.1016/j.biopha.2023.114627. Epub 2023 Apr 3. Biomed Pharmacother. 2023. PMID: 37018985 Free article.
Intragenic NF1 deletions in sinonasal mucosal malignant melanoma.
Riobello C, Casanueva Muruais R, Suárez-Fernández L, García-Marín R, Cabal VN, Blanco-Lorenzo V, Franchi A, Laco J, López F, Llorente JL, Hermsen MA. Riobello C, et al. Among authors: blanco lorenzo v. Pigment Cell Melanoma Res. 2022 Jan;35(1):88-96. doi: 10.1111/pcmr.13015. Epub 2021 Oct 8. Pigment Cell Melanoma Res. 2022. PMID: 34547192
Aberrant Signaling Pathways in Sinonasal Intestinal-Type Adenocarcinoma.
Riobello C, Sánchez-Fernández P, Cabal VN, García-Marín R, Suárez-Fernández L, Vivanco B, Blanco-Lorenzo V, Álvarez Marcos C, López F, Llorente JL, Hermsen MA. Riobello C, et al. Among authors: blanco lorenzo v. Cancers (Basel). 2021 Oct 7;13(19):5022. doi: 10.3390/cancers13195022. Cancers (Basel). 2021. PMID: 34638506 Free PMC article.
Characterization of a Preclinical In Vitro Model Derived from a SMARCA4-Mutated Sinonasal Teratocarcinosarcoma.
Lorenzo-Guerra SL, Codina-Martínez H, Suárez-Fernández L, Cabal VN, García-Marín R, Riobello C, Vivanco B, Blanco-Lorenzo V, Sánchez-Fernández P, López F, Llorente JL, Hermsen MA. Lorenzo-Guerra SL, et al. Among authors: blanco lorenzo v. Cells. 2023 Dec 30;13(1):81. doi: 10.3390/cells13010081. Cells. 2023. PMID: 38201285 Free PMC article.
Fatal sclerosing mesenteritis: a 7-year-old male autopsy case report.
Celis Pinto JC, Hernández Peláez L, Mendoza Pacas G, Mayordomo Colunga J, Balbín M, Pitiot A, Torres-Rivas HE, Blanco Lorenzo V. Celis Pinto JC, et al. Among authors: blanco lorenzo v. Autops Case Rep. 2023 May 31;13:e2023434. doi: 10.4322/acr.2023.434. eCollection 2023. Autops Case Rep. 2023. PMID: 37292389 Free PMC article.
Mithramycin delivery systems to develop effective therapies in sarcomas.
Estupiñán Ó, Niza E, Bravo I, Rey V, Tornín J, Gallego B, Clemente-Casares P, Moris F, Ocaña A, Blanco-Lorenzo V, Rodríguez-Santamaría M, Vallina-Álvarez A, González MV, Rodríguez A, Hermida-Merino D, Alonso-Moreno C, Rodríguez R. Estupiñán Ó, et al. Among authors: blanco lorenzo v. J Nanobiotechnology. 2021 Sep 6;19(1):267. doi: 10.1186/s12951-021-01008-x. J Nanobiotechnology. 2021. PMID: 34488783 Free PMC article.
Prognostic Significance of β-Catenin in Relation to the Tumor Immune Microenvironment in Oral Cancer.
Lequerica-Fernández P, Rodríguez-Santamarta T, García-García E, Blanco-Lorenzo V, Torres-Rivas HE, Rodrigo JP, Suárez-Sánchez FJ, García-Pedrero JM, De Vicente JC. Lequerica-Fernández P, et al. Among authors: blanco lorenzo v. Biomedicines. 2023 Sep 29;11(10):2675. doi: 10.3390/biomedicines11102675. Biomedicines. 2023. PMID: 37893049 Free PMC article.
[Liver sarcoma in a patient with cirrhosis and prior hepatocellular carcinoma].
Alonso-Galán H, Mesa-Alvarez A, Blanco-Lorenzo V, Amor-Martín P, Vázquez L, Rodríguez M, Varela M. Alonso-Galán H, et al. Among authors: blanco lorenzo v. Gastroenterol Hepatol. 2013 Jan;36(1):39-42. doi: 10.1016/j.gastrohep.2012.08.002. Epub 2012 Oct 31. Gastroenterol Hepatol. 2013. PMID: 23122427 Review. Spanish. No abstract available.
GARP promotes the proliferation and therapeutic resistance of bone sarcoma cancer cells through the activation of TGF-β.
Carrillo-Gálvez AB, Quintero JE, Rodríguez R, Menéndez ST, Victoria González M, Blanco-Lorenzo V, Allonca E, de Araújo Farias V, González-Correa JE, Erill-Sagalés N, Martínez-Zubiaurre I, Hellevik T, Sánchez-Hernández S, Muñoz P, Zurita F, Martín F, Rodríguez-Manzaneque JC, Anderson P. Carrillo-Gálvez AB, et al. Among authors: blanco lorenzo v. Cell Death Dis. 2020 Nov 17;11(11):985. doi: 10.1038/s41419-020-03197-z. Cell Death Dis. 2020. PMID: 33203838 Free PMC article.
14 results